Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Avichai Shimoni

Showing results (121-130 of 165) with videos related to

Pageof 17
Sort By:
Journal of Hematology & Oncology|November 9, 2016
Long-term survival and late events after allogeneic stem cell transplantation from HLA-matched siblings for acute myeloid leukemia with myeloablative compared to reduced-intensity conditioning: a report on behalf of the acute leukemia working party of European group for blood and marrow transplantationAvichai Shimoni, Myriam Labopin, Bipin Savani, et al.
Genome Medicine|July 17, 2025
Microbiome-based prediction of allogeneic hematopoietic stem cell transplantation outcomeOshrit Shtossel, Adi Eshel, Shalev Fried, et al.
British Journal of Haematology|May 23, 2019
Second allogeneic stem cell transplantation in patients with acute lymphoblastic leukaemia: a study on behalf of the Acute Leukaemia Working Party of the European Society for Blood and Marrow TransplantationArnon Nagler, Myriam Labopin, Bhagirathbhai Dholaria, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 5, 2019
Comparable Long-Term Outcome after Allogeneic Stem Cell Transplantation from Sibling and Matched Unrelated Donors in Patients with Acute Myeloid Leukemia Older Than 50 Years: A Report on Behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow TransplantationAvichai Shimoni, Myriam Labopin, Bipin Savani, et al.
American Journal of Blood Research|September 3, 2013
Treatment of severe steroid resistant acute GVHD with mesenchymal stromal cells (MSC)Igor B Resnick, Claudine Barkats, Michael Y Shapira, et al.
Leukemia & Lymphoma|September 16, 2022
Point-of-care CAR T-cell therapy as salvage strategy for out-of-specification tisagenlecleucelShalev Fried, Roni Shouval, Nira Varda-Bloom, et al.
Oncotarget|February 10, 2018
Thiotepa-busulfan-fludarabine compared to busulfan-fludarabine for sibling and unrelated donor transplant in acute myeloid leukemia in first remissionFrancesco Saraceni, Myriam Labopin, Rose-Marie Hamladji, et al.
Experimental Hematology|June 3, 2009
Post-transplant immunotherapy with donor-lymphocyte infusion and novel agents to upgrade partial into complete and molecular remission in allografted patients with multiple myelomaNicolaus Kröger, Anita Badbaran, Michael Lioznov, et al.
British Journal of Haematology|August 14, 2025
Graft-versus-host disease is not associated with reduced incidence of relapse following haploidentical stem cell transplantation with post-transplant cyclophosphamide for acute lymphoblastic leukaemia: A study on behalf of the Acute Leukaemia Working Party of European Society for Blood and Marrow TransplantationAvichai Shimoni, Christophe Peczynski, Myriam Labopin, et al.
Haematologica|March 15, 2015
The impact of graft-versus-host disease prophylaxis in reduced-intensity conditioning allogeneic stem cell transplant in acute myeloid leukemia: a study from the Acute Leukemia Working Party of the European Group for Blood and Marrow TransplantationMarie Thérèse Rubio, Myriam Labopin, Didier Blaise, et al.
Pageof 17

Showing results (121-130 of 165) with videos related to

Sort By:
Pageof 17
Journal of Hematology & Oncology|November 9, 2016
Long-term survival and late events after allogeneic stem cell transplantation from HLA-matched siblings for acute myeloid leukemia with myeloablative compared to reduced-intensity conditioning: a report on behalf of the acute leukemia working party of European group for blood and marrow transplantationAvichai Shimoni, Myriam Labopin, Bipin Savani, et al.
Genome Medicine|July 17, 2025
Microbiome-based prediction of allogeneic hematopoietic stem cell transplantation outcomeOshrit Shtossel, Adi Eshel, Shalev Fried, et al.
British Journal of Haematology|May 23, 2019
Second allogeneic stem cell transplantation in patients with acute lymphoblastic leukaemia: a study on behalf of the Acute Leukaemia Working Party of the European Society for Blood and Marrow TransplantationArnon Nagler, Myriam Labopin, Bhagirathbhai Dholaria, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 5, 2019
Comparable Long-Term Outcome after Allogeneic Stem Cell Transplantation from Sibling and Matched Unrelated Donors in Patients with Acute Myeloid Leukemia Older Than 50 Years: A Report on Behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow TransplantationAvichai Shimoni, Myriam Labopin, Bipin Savani, et al.
American Journal of Blood Research|September 3, 2013
Treatment of severe steroid resistant acute GVHD with mesenchymal stromal cells (MSC)Igor B Resnick, Claudine Barkats, Michael Y Shapira, et al.
Leukemia & Lymphoma|September 16, 2022
Point-of-care CAR T-cell therapy as salvage strategy for out-of-specification tisagenlecleucelShalev Fried, Roni Shouval, Nira Varda-Bloom, et al.
Oncotarget|February 10, 2018
Thiotepa-busulfan-fludarabine compared to busulfan-fludarabine for sibling and unrelated donor transplant in acute myeloid leukemia in first remissionFrancesco Saraceni, Myriam Labopin, Rose-Marie Hamladji, et al.
Experimental Hematology|June 3, 2009
Post-transplant immunotherapy with donor-lymphocyte infusion and novel agents to upgrade partial into complete and molecular remission in allografted patients with multiple myelomaNicolaus Kröger, Anita Badbaran, Michael Lioznov, et al.
British Journal of Haematology|August 14, 2025
Graft-versus-host disease is not associated with reduced incidence of relapse following haploidentical stem cell transplantation with post-transplant cyclophosphamide for acute lymphoblastic leukaemia: A study on behalf of the Acute Leukaemia Working Party of European Society for Blood and Marrow TransplantationAvichai Shimoni, Christophe Peczynski, Myriam Labopin, et al.
Haematologica|March 15, 2015
The impact of graft-versus-host disease prophylaxis in reduced-intensity conditioning allogeneic stem cell transplant in acute myeloid leukemia: a study from the Acute Leukemia Working Party of the European Group for Blood and Marrow TransplantationMarie Thérèse Rubio, Myriam Labopin, Didier Blaise, et al.
Pageof 17